Tenaya Therapeutics, Inc. - Common Stock, par value $0.0001 per share (TNYA)

Historical Holders from Q3 2021 to Q3 2025

Symbol
TNYA on Nasdaq
Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
213M
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
34.5M
Holdings value
$55.5M
% of all portfolios
0%
Grand Portfolio weight change
+0%
Number of holders
89
Number of buys
34
Number of sells
-47
Average Value change %
+0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Tenaya Therapeutics, Inc. - Common Stock, par value $0.0001 per share (TNYA)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
COLUMN GROUP III, LP 23.1% -24% $67.1M 49.3M 0% The Column Group Opportunity III, LP 15 Dec 2025
Woodline Partners LP 4.99% -25.9% $6.12M $2.1M 9M +52.1% Woodline Partners LP 30 Jun 2025
Empery Asset Management, LP 4.99% -49.7% $5.64M -$293K 8.3M -4.94% Empery Asset Management, LP 30 Jun 2025
Casdin Capital, LLC 4.3% $3.23M 6.73M Casdin Capital, LLC 04 Mar 2025
BlackRock, Inc. 1.7% -71.4% $1.67M -$1.57M 2.73M -48.4% BlackRock, Inc. 30 Jun 2025
JPMORGAN CHASE & CO 2.8% -52.9% $1.1M -$1.38M 2.28M -55.7% JPMORGAN CHASE & CO. 28 Feb 2025

Institutional Holders of Tenaya Therapeutics, Inc. - Common Stock, par value $0.0001 per share (TNYA)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 34.5M $55.5M +$5.33M $1.62 89
2025 Q2 31.6M $19.3M -$9.94M $0.61 87
2025 Q1 48.2M $27.5M +$1.98M $0.57 104
2024 Q4 43.6M $62.4M -$25.8M $1.43 83
2024 Q3 57.6M $111M +$67K $1.93 91
2024 Q2 57.1M $177M +$2.25M $3.10 94
2024 Q1 56M $293M +$51.2M $5.23 89
2023 Q4 46.6M $151M -$9.23M $3.24 73
2023 Q3 49.7M $127M -$3.31M $2.55 77
2023 Q2 47.7M $280M +$15.9M $5.87 79
2023 Q1 45M $128M -$2.29M $2.85 65
2022 Q4 47.1M $94.7M +$23M $2.01 67
2022 Q3 35.2M $102M -$12.2M $2.90 67
2022 Q2 37.1M $209M -$1.86M $5.63 47
2022 Q1 37.3M $440M +$23.3M $11.78 50
2021 Q4 35.4M $668M +$18.1M $18.95 46
2021 Q3 24.5M $499M +$499M $20.65 44